Edgar Lomax CO Organon & Co. Transaction History

Edgar Lomax CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.67 Million - $2.16 Million	-54,914 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $13,044 - $16,894	-455 Reduced 0.82%	54,914 $1.67 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $45,235 - $56,311	-1,580 Reduced 2.77%	55,369 $1.82 Million
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $1.62 Million - $2.16 Million	56,949 New	56,949 $1.72 Million

785

189M

2.46M

2.27M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.26B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

Stay updated on Edgar Lomax CO with notifications on news.